News

In the first two cohorts of healthy volunteers, the safety, tolerability, pharmacokinetics and optimal formulation of the candidate compound will be evaluated during a placebo controlled dose escalation.

Under the agreement, Oncolys may receive up to $286m as well as upfront, development, regulatory and sales milestone payments. In addition, Oncolys is eligible to receive tiered royalties

Megapharm is EpiCept’s partner in Israel and upon Ministry of Health approval of labeling and other technical matters the company is expected to launch Ceplene in the first

The technology creates transient bonds between larger molecules such as proteins and peptides, including insulin, and a carrier.Ascendis Pharma claims that the TransCon Linker technology has shown promising

Haojishi is an anti-inflammatory analgesic poultice that contains glycol salicylate and menthol as two of its main ingredients. Available in China as a prescription medication, the product comes

The new, 23,000 square meter innovation center, which will provide space for 500 people, is due to be completed by the end of 2012. The new innovation center

Auspex is a clinical stage biotechnology company focused on the discovery and development of novel therapeutics based on site-specific deuteration of promising drug candidates and clinically validated drugs.

Recently, the South African government has floated a R4.28bn national ARV drugs tender. Sonke Pharmaceuticals, a JV between Ranbaxy (Pty) (70% stake) and Community Investment Holdings (30% stake),

Mankind has already established two manufacturing units at Paonta Sahib in Sirmaur district of Himachal Pradhesh. Mankind Pharma plans to add mosquito repellent, shoe polish and shaving cream